These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 4074431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term effect of cilostazol on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S, Yamaguchi S, Katsube T, Kitani M, Okada K, Tsunematsu T.
    Arzneimittelforschung; 1985; 35(7A):1193-7. PubMed ID: 4074433
    [Abstract] [Full Text] [Related]

  • 9. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 10. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.
    Ohashi S, Iwatani M, Hyakuna Y, Morioka Y.
    Arzneimittelforschung; 1985; 35(7A):1203-8. PubMed ID: 4074436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased external carotid artery blood flow in headache patients induced by cilostazol. Preliminary communication.
    Yamashita K, Kobayashi S, Okada K, Tsunematsu T.
    Arzneimittelforschung; 1990 May; 40(5):587-8. PubMed ID: 2383301
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man.
    Akiyama H, Kudo S, Shimizu T.
    Arzneimittelforschung; 1985 May; 35(7A):1133-40. PubMed ID: 4074424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
    Vilahur G, Pena E, Padró T, Badimon L.
    Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
    [Abstract] [Full Text] [Related]

  • 18. Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency.
    Kawamura K, Fujita S, Tani T, Kimura Y.
    Arzneimittelforschung; 1985 Apr; 35(7A):1154-6. PubMed ID: 4074428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH, Hwang JY, Kim IS, Park Y, Hwang SJ, Lee SW, Kwak CH, Park SW.
    Circ Cardiovasc Interv; 2010 Feb 01; 3(1):17-26. PubMed ID: 20118150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.